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e-mail address: zafceb@gmail.com (Z. Cebeci).Zafer Cebeci ⇑; Serife Bayraktar; Merih Oray; Nur KirAbstractTo report the fundus findings on multimodal imaging of a membranoproliferative glomerulonephritis type II (MPGNII) patient.
A 41-year-old woman had a medical history of renal transplantation for MPGNII 5 years prior to presentation to our clinic for
ophthalmic examination. Fundus examination showed macular retinal pigment epithelial changes and large peripapillary atrophy
in the right eye, and yellowish bilateral drusen-like deposits peripherally. Fundus fluorescein angiography and indocyanine green
angiography revealed multifocal hyperfluorescence in the peripheral retina with accompanying deposits. A hyperautofluorescence
pattern was seen in the fundus autofluorescence (FAF) images of the deposits. Spectral domain optical coherence tomography
(SD-OCT) scans of the drusen-like material showed retinal pigment epithelium (RPE) elevations with moderate hyperreflectivity
underneath. Multiple imaging modalities of the posterior segment can provide detailed information about the ocular involvement
of MPGNII and help us to confirm the diagnosis and to follow the lesions.
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Membranoproliferative glomerulonephritis type II
(MPGNII), also known as dense deposit disease, is an inflam-
mation of the glomerulus and one of the major causes of
nephrotic syndrome. The main mechanism of the disease is
regulation failure of the complement cascade alternative
pathway.1 Electron-dense transformation of the glomerular
basement membrane (GBM) is the characteristic histopatho-
logical feature of MPGNII.2 Constitution of dense deposits
seen in the renal capillary tuft/GBM/glomerular epithelial
interface is analogous to deposits detected in the choroid/
Bruch’s membrane/retinal pigment epithelium (RPE)
interface.3
Visual prognosis usually depends on complications sec-
ondary to deposit formation. Visual impairment may resultfrom the choroidal neovascular membrane, central serous
chorioretinopathy, or macular detachment.4,5
Herein, we present the findings of multimodal imaging of
the fundus in a patient with MPGNII who had undergone
renal transplantation.Case report
A 41-year-old female patient was admitted to our clinic for
routine ophthalmological examination. She had a complaint
of vision decrease in her right eye since 10 years. She never
had any treatment for her ocular complaints. Past medical
history included diagnosis of MPGNII at the age of 15 years.
Based on her past medical records, she had undergone renal
transplantation for end-stage renal disease 5 years ago and
had no evidence of MPGNII recurrence on the transplante:
al.com
Membranoproliferative glomerulonephritis type II 261tissue, according to the nephrology consultation. On oph-
thalmic examination, her visual acuity was 20/200 in the right
eye and 20/20 in the left eye. Anterior segments were normal
bilaterally. Fundus examination showed retinal pigment
epithelial changes on the macula, peripapillary atrophic areasFigure 1. Fundus photograph of the right eye shows retinal pigment epithelia
Fundus photograph of the left eye demonstrates drusen like deposits in the p
Figure 2. Fluorescein angiography (FA) of the right eye illustrates large perip
late (i) phases. FA of the left eye shows window defect superotemporally to th
(g), and late (k) phases. Indocyanine green angiography (ICG-A) demonstrate
spots from early to late phases in the right eye (b, f, j) and hyperfluorescent spotextending superiorly and inferiorly in the right eye, and
yellow-white, elevated, basal laminar drusen-like lesions
peripherally in both eyes (Fig. 1a and b). Fundus fluorescein
angiography (FFA) showed hyperfluorescence in the macula
and peripapillary region in the right eye, superotemporallyl changes on macula and drusen like deposits in the peripheral retina (a).
eriphery (b).
apillary hyperfluorescence due to window defect in early (a), mid (e), and
e optic disc and hyperfluorescence spots in the periphery in early (c), mid
s marked peripapillary hypofluorescence and scattered hyperfluorescent
s becoming moremarked in the late phases of ICG-A in the left eye (d, h, l).
Figure 3. Hyperfluorescence spots due to drusen like deposits in the
superior periphery in early to late phases of FA in the left eye (a, c, e).
ICG-A demonstrates prominent hyperfluorescent spots in late phases,
consistent with the deposits in the same area (b, d, f). Fundus autoflu-
orescence shows hyperautofluorescence in the deposit areas (g).
262 Z. Cebeci et al.of the optic disc in the left eye due to a window defect and
multiple small, round, well-defined hyperfluorescent spots
throughout the peripheral fundus due to staining of drusen-like lesions in both eyes and indocyanine green angiography
(ICG-A) revealed small hyperfluorescent areas corresponding
to the drusen-like lesions bilaterally (Figs. 2a–l, 3a–f). Fundus
autofluorescence (FAF) showed multiple hyperautofluores-
cent spots in the areas of peripheral deposit lesions in both
eyes (Fig. 3g). Spectral-domain optical coherence tomogra-
phy (SD-OCT) images of the macula revealed loss of the inner
segment/outer segment (IS/OS) of photoreceptors in the
right eye (Fig. 4a), and were normal in the left eye. OCT scans
from the deposits showed focal RPE elevations and bumps,
with moderate reflectivity below these elevations (Fig. 4b).
Based on clinical examination and imaging, fundus lesions
were diagnosed as retinal findings of MPGNII and the patient
will continue to follow up in our retina department.Discussion
Membranoproliferative glomerulonephritis type II is a rare
and progressive renal disease that can cause end-stage renal
disease. The disease usually presents in the early adulthood
and patients often develop drusen-like deposits in the sec-
ond decade of life, but also visual loss can occur at older
ages.6 Histopathologically, abnormal dense deposits in the
Bruch’s membrane and choriocapillaris in an MPGNII patient
were first reported by Duvall-Young et al. in 1989.7 D’Souza
et al. showed that drusen-like deposits in MPGNII share com-
mon compositions with the drusen in age-related macular
degeneration (AMD) and suggested that deposits are the
end result of both diseases.3 The alternative complement
pathway system components play a critical role in the patho-
genesis of MPGNII, and the same factors take part in drusen
formation in AMD.8
Fundus fluorescein angiography and ICG-A have been
shown to demonstrate abnormal hyperfluorescent dots,
which are possible links to the vascular pathology in the
choriocapillaris.9
Optical coherence tomography scans of the deposits show
similar structural features with soft drusen detected in
AMD.10,11 Scans of the drusen-like lesions show alterations
in RPE with elevations accompanying moderate-to-highly
reflective material beneath the elevations. In some cases, a
hyporeflective image can be seen under the RPE elevations.11
Drusen, especially soft types, shows increased signals on
FAF images because of excessive lipofuscin accumulation.
Einbock et al. stated that focal or plaque-like FAF changes
in the macula carry a high risk for the progression of geo-
graphic atrophy.12 Our case had large peripapillary atrophic
areas extending to the superior and inferior fundus. The pos-
sible mechanism may be intense drusen-like deposits around
the optic disc causing atrophic changes over time, as seen in
AMD.
Visual loss develops due to secondary changes in patients
with prolonged fundus findings. Choroidal neovascularization
(CNV), central serous chorioretinopathy, and atrophic macula
are the main complications that can occur in the course of the
disease.4,5
Lesions in the fundus can be seen long after renal trans-
plantation with stable renal status.13 Also, it has been shown
that renal transplantation did not affect the development of
CNV in 4 patients with long-term follow-up.13 However,
Abazi et al. reported that renal transplantation can provoke
the development of retinopathy, including hemorrhages
Figure 4. OCT of the right macula demonstrates loss of IS/OS line (a). Scans from the deposits show pigment epithelial irregularity and elevations with
underlying moderate hyperreflective material (b).
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nal fluid or choroidal neovascularization in our patient with
any of the imaging modalities. In our case, macular and large
peripapillary RPE changes and atrophic areas in the right eye
might be sequelae of presumed previous serous retinal
detachment. However, our patient experienced visual loss
in her right eye for 5 years prior to the transplantation and
reported no worsening or new complaints after the
transplantation.
Histopathological and imaging studies have shown that
lesions in AMD and MPGNII share many features in common.
However, further investigations with larger groups of patients
must be done to differentiate the characteristics between the
drusen in AMD and the deposits in MPGNII.
In conclusion, fundus findings may persist for a long time
period following renal transplantation. Multimodal imaging
may be helpful for the clinicians to diagnose and also to fol-
low the posterior segment changes in patients with MPGNII.
In addition, clinicians must be aware of the development of
complications secondary to lesions, and periodic ophthalmic
examinations must be performed in MPGNII patients.
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